GlassScriptPhysician profile
Ernest C Quintin
NPI 1134488190
$1,979.25
in general payments reported to CMS, 2019-2025
19 companies · $925 in 2025
The $925 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.60 · 2020: $13.73 · 2021: $12.00 · 2022: $250 · 2024: $679 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046 · Consulting Fee: $525 · Education: $32.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.98 |
| Consulting Fee | $525.00 |
| Education | $32.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $787.58 | 2024-2025 | Imfinzi, Enhertu, Lynparza |
| Novocure Gmbh | $250.00 | 2022 | |
| Janssen Biotech, INC. | $114.66 | 2025 | Talvey, Rybrevant |
| Celgene Corporation | $98.60 | 2025 | Opdivo, Reblozyl |
| Abbvie INC. | $97.61 | 2024 | |
| Novartis Pharmaceuticals Corporation | $94.07 | 2019-2025 | |
| Daiichi Sankyo INC. | $81.95 | 2025 | Datroway, Enhertu |
| Sanofi-Aventis U.S. LLC | $64.99 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.44 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $59.54 | 2025 | Opdualag, Opdivo |
| Merck Sharp & Dohme LLC | $49.22 | 2019-2025 | Lynparza, Keytruda Qlex, Keytruda |
| Genzyme Corporation | $46.52 | 2025 | |
| Jazz Pharmaceuticals INC. | $34.81 | 2025 | |
| Astellas Pharma US INC | $31.85 | 2025 | Padcev |
| Sobi, INC | $30.51 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $23.84 | 2025 | Monjuvi |
| Beone Medicines USA, INC. | $20.99 | 2025 | Brukinsa |
| Caris Mpi, INC. | $17.07 | 2025 | Mi Cancer Seek |
| Alexion Pharmaceuticals, INC. | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Quintin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.